Opti Capital Management, LP - Q3 2021 holdings

$1.07 Billion is the total value of Opti Capital Management, LP's 35 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 0.0% .

 Value Shares↓ Weighting
 NEW RELIC INCnote 0.500% 5/0$67,716,000
+1.4%
66,728,0000.0%6.35%
-11.3%
 COHERUS BIOSCIENCES INCnote 1.500% 4/1$32,235,000
+7.6%
29,150,0000.0%3.02%
-5.8%
 FORTIVE CORPnote 0.875% 2/1$32,087,000
+0.1%
31,927,0000.0%3.01%
-12.4%
 KBR INCnote 2.500%11/0$25,747,000
+2.5%
16,000,0000.0%2.42%
-10.3%
 NUVASIVE INCnote 1.000% 6/0$22,927,000
-2.3%
22,410,0000.0%2.15%
-14.5%
 OMEROS CORPnote 6.250%11/1$14,388,000
-2.5%
13,200,0000.0%1.35%
-14.7%
 PEGASYSTEMS INCnote 0.750% 3/0$13,045,000
-5.2%
11,500,0000.0%1.22%
-17.1%
 FLEXION THERAPEUTICS INCnote 3.375% 5/0$11,742,000
-1.8%
13,158,0000.0%1.10%
-14.0%
 PTC THERAPEUTICS INCnote 3.000% 8/1$8,383,000
-4.1%
8,000,0000.0%0.79%
-16.0%
 IRONWOOD PHARMACEUTICALS INCnote 0.750% 6/1$6,265,000
+0.7%
5,300,0000.0%0.59%
-11.8%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SUPERNUS PHARMACEUTICALS INC14Q1 20236.9%
NEW RELIC INC14Q1 20237.6%
8X8 INC NEW13Q3 20237.4%
MANDIANT INC12Q1 20229.9%
NUTANIX INC12Q4 20227.3%
OPKO HEALTH INC12Q3 20232.1%
INSIGHT ENTERPRISES INC10Q3 20235.6%
ALTERYX INC10Q3 20234.6%
IONIS PHARMACEUTICALS INC10Q1 20233.6%
MODEL N INC10Q3 20231.7%

View Opti Capital Management, LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14

View Opti Capital Management, LP's complete filings history.

Compare quarters

Export Opti Capital Management, LP's holdings